Viroblock has developed a unique anti-microbial fabric based on its proprietary cholesterol sequestration technology.  Capable of inactivating H5N1 and other enveloped viruses on pass through air, the fabric opens a new chapter in air filtration.  Unlike regular face-masks (e.g., N95 or FFP2) that have only a limited ability to remove enveloped viruses from pass through air, the new Viroblock mask will capture and kill  more that 99.9% of respiratory enveloped viruses as they try to pass through the mask or filter.  Viroblock is now working to bring this new technology to the market in a range of air filtration products that will help protect users from the increasingly virulent strains of virus found in today’s world.

In addition to anti-microbial fabrics, Viroblock is exploring the use of this technology in a number of other applications. These include a potentially protective nasal spray, hand and surface cleaners and eventually the possibility of using this technology as a microbicide against AIDS and Herpes.